Breaking News Instant updates and real-time market news.

UAA

Under Armour

$17.74

-3.42 (-16.16%)

12:01
11/04/19
11/04
12:01
11/04/19
12:01

Under Armour falls -16.1%

Under Armour is down -16.1%, or -$3.40 to $17.74.

  • 04

    Nov

UAA Under Armour
$17.74

-3.42 (-16.16%)

09/12/19
PIPR
09/12/19
NO CHANGE
PIPR
Overweight
Under Armour checks show promotions tracking below last year, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says her channel checks quarter-to-date suggest promotional activity for Under Armour (UAA) continues to track slightly below last year's levels and that new product is resonating well. With her price target of $30 offering 40% upside from current levels, the analyst is revisiting the shares as a "favorite name" into Q4. Under Armour is more focused against a "cleaner" athletic backdrop and incremental innovation in apparel and footwear should accelerate in 2020, Murphy tells investors in a research note. She keeps an Overweight rating on the name.
09/25/19
JEFF
09/25/19
NO CHANGE
Target $97
JEFF
Hold
Nike price target raised to $97 from $80 at Jefferies
Jefferies analyst Randal Konik raised his price target for Nike (NKE) to $97 from $80 saying the "broad-based, strong" 10% constant currency growth in last night's Q1 illustrates the ongoing power of its brand. However, these positives are fully contemplated in the shares at current levels, Konik tells investors in a post-earnings research note. The analyst, who prefers shares of Foot Locker (FL) and Under Armour (UAA), keeps a Hold rating on Nike.
10/09/19
JEFF
10/09/19
NO CHANGE
JEFF
Buy
Under Armour product selling out, discounting is down, says Jefferies
Jefferies analyst Randal Konik says his September webscrapes illustrate that the overall athletic category "remains very strong." The highlight is Under Armour's (UAA) percentage of product on discount, which was down for each month in Q3 with strength coming from the HOVR platform, Konik tells investors in a research note. He believes the company's product is selling out, discounting is down, and inventory is controlled. Data also revealed traction in the Adidas (ADDYY) Ultraboost at retail, and Nike (NKE) "increasingly dominating" the secondary market with Jordan and Air Force platforms, says the analyst.
10/23/19
SBSH
10/23/19
NO CHANGE
SBSH
Buy
CEO change positive for Under Armour story, says Citi
Citi analyst Paul Lejuez views the announcement that President and COO Patrik Frisk will replace Kevin Plank as Under Armour CEO, effective January 1, as a positive for the story. Frisk has been pivotal in helping the organization "grow up" by focusing more on profitability, Lejuez tells investors in a research note. He believes investors are getting the "best of both worlds," with Frisk in charge of the day-to- day and Plank still playing an important role as the face of the brand. Lejuez keeps a Buy rating on Under Armour shares.

TODAY'S FREE FLY STORIES

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

, EIGI

Endurance

$4.04

-0.06 (-1.46%)

17:03
12/05/19
12/05
17:03
12/05/19
17:03
Hot Stocks
TripAdvisor acquires SinglePlatform from Endurance, terms not disclosed »

TripAdvisor (TRIP)…

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

EIGI

Endurance

$4.04

-0.06 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.63

-0.45 (-1.21%)

, COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

16:56
12/05/19
12/05
16:56
12/05/19
16:56
Periodicals
OPEC cancels customary press conference after meeting, CNBC reports »

Amid reports that OPEC…

BP

BP

$36.63

-0.45 (-1.21%)

COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

TOT

Total

$52.29

0.02 (0.04%)

XOM

Exxon Mobil

$68.41

-0.24 (-0.35%)

CVX

Chevron

$116.30

-0.66 (-0.56%)

RDS.A

Royal Dutch Shell

$56.50

-0.34 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

16:53
12/05/19
12/05
16:53
12/05/19
16:53
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$75.68

0.67 (0.89%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Hot Stocks
Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Earnings
Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Upgrade
Epizyme rating change  »

Epizyme upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

ESTA

Establishment Labs

$24.31

0.32 (1.33%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Hot Stocks
Establishment Labs reaches one million Motiva implants milestone »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDT

IDT Corp

$7.47

0.26 (3.61%)

16:34
12/05/19
12/05
16:34
12/05/19
16:34
Earnings
IDT Corp reports Q1 EPS 10c vs. (2c) last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

KODK

Kodak

$2.59

0.085 (3.39%)

16:33
12/05/19
12/05
16:33
12/05/19
16:33
Hot Stocks
Kodak's Karfunkel acquires over 4.4M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAC

GAP Airports

$99.66

-1.12 (-1.11%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
GAP Airports reports November traffic up 10.1% »

GAP Airports announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$19.49

0.7 (3.73%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
St. Joe, HomeCorp to build additional 120 apartment homes in Panama City Beach »

The St. Joe Company and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.44

-0.17 (-0.87%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
Alector announces FDA fast track designation granted to AL001 for dementia »

Alector announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGLN

Magellan Health

$76.79

-0.12 (-0.16%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Magellan Health names James Murray as President and COO »

Magellan Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWIR

Sierra Wireless

$9.15

0.12 (1.33%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Sierra Wireless CFO Dave McLennan retiring in mid-2020 »

Sierra Wireless CFO Dave…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

ASR

Asur

$167.79

-1.88 (-1.11%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Asur reports total November passenger traffic up 7.3% »

Asur announced that total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$25.05

0.92 (3.81%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Integrated Core Strategies reports 5.1% passive stake in Axonics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$313.10

1 (0.32%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Earnings
Cooper Companies sees Q1 EPS $2.65-$2.75, consensus $2.97 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Options
Preliminary option volume of 14.7M today »

Preliminary option volume…

COO

Cooper Companies

$312.96

0.86 (0.28%)

16:28
12/05/19
12/05
16:28
12/05/19
16:28
Earnings
Cooper Companies sees FY20 EPS $12.60-$13.30, consensus $13.10 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Downgrade
Audentes Therapeutics, Astellas Pharma rating change  »

Audentes Therapeutics…

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.